The Firm recently represented Deutsche Bank, J.P. Morgan, MUFG and Credit Suisse as bookrunners for a $5.75 billion offering by Roche Holdings, Inc. of notes, guaranteed by Roche Holding Ltd. The offering consisted of six series of notes, including three-year and five-year floating rate notes and three-year, five-year, seven-year, and ten-year fixed rate notes. The offering was conducted in reliance upon Rule 144A and Regulation S under the Securities Act of 1933. The proceeds of the offering were used for general corporate purposes, including the funding of Roche’s tender offer for the shares of Intermune, Inc.
The Roche Group is a leading international research-focused healthcare group which operates in more than 150 countries. Based on 2013 sales, the Roche Group was among the world’s largest producers of pharmaceuticals and was the world’s leading supplier of in vitro diagnostics.
The Simpson Thacher team for the transaction included Mark Brod, Rohan Kaul and Vanessa Tisci (Capital Markets); Alexander Key (Intellectual Property); Taylor Alexander (Tax); Michael Isby (Environmental); and Jennie Getsin (Blue Sky).
Source: www.stblaw.com
